Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds useful as inhibitors of ATR kinase and combination therapies thereof

Compounds useful as inhibitors of ATR kinase and combination therapies thereof

US Patent 11110086 · Granted Sep 7, 2021

Estimated economic value: $188,614,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biomarkers and methods for detection of seizures and epilepsy2023
Method for treating cancer using a combination of DNA damaging agents and ATR in2022
Method for treating cancer using a combination of DNA damaging agents and ATR in2022
Method for treating cancer using a combination of DNA damaging agents and ATR in2022
Biomarkers for seizures2021
Substituted pyrazines as ATR kinase inhibitors2021
Treating cancer with ATR inhibitors2020
Treating cancer with ATR inhibitors2020
Compounds useful as inhibitors of ATR kinase and combination therapies thereof2019
Compounds useful as inhibitors of ATR kinase and combination therapies thereof2019
Compounds useful as inhibitors of ATR kinase and combination therapies thereof2019
Substituted pyrazin-2-amines as inhibitors of ATR kinase2019